博济医药: 第五届董事会第十四次会议决议公告

Group 1 - The board meeting of Boji Pharmaceutical Technology Co., Ltd. was held on June 6, 2025, with all 7 directors present, confirming compliance with relevant laws and regulations [1][2] - The board approved the cancellation of unexercised stock options from the second exercise period of the 2022 stock option incentive plan, as some incentive targets did not fully exercise their options [1][2] - The voting results for the proposal were unanimous, with 7 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The supervisory board provided a review opinion on the proposal, and a law firm issued a legal opinion regarding the matter [2] - The proposal was also approved by the company's remuneration and assessment committee [2] - Relevant details were disclosed on the official website for further reference [2]